Hologic : Sustaiability Report (2024 Hologic Sustainability Report)

Published: 2025-04-21 19:10:09 ET HOLX

2024 Sustainability Report

Helping women around

the world live healthier lives.

Hologic 2024 Sustainability Report

For us, women's health is more than a business, it is our purpose.

Table of Contents

Our report has been designed to provide an integrated view of our sustainability program. It also reflects the most important environmental, social and governance themes affecting our business. This report has been prepared with reference to the Global Reporting Initiative (GRI), the recommendations from the Task Force on Climate-related Financial Disclosures (TCFD) and is aligned to the Sustainability Accounting Standards Board (SASB) sections applicable to our industry.

Our annual sustainability report reflects our purpose in action covering fiscal year October 1, 2023, to September 28, 2024, unless otherwise noted. This document reflects the progress we have made and our commitments toward building a healthier world.

11 Advancing Access and Equity for Women's Health

28 Protecting the Environment

30 Drive Climate Action

37 Conserve Natural Resources and Reduce our Environmental Footprint

44 Integrate Eco Design in Products and Packaging

For additional information, see About the Report in the Appendix.

We welcome your feedback at [email protected].

Supporting Our People

Operating With Integrity

Appendix

and Communities

Uphold Strong Corporate Governance

About this Report

Nurture an Inclusive and Engaged Culture

and Compliance

Data Summary

Conduct Responsible Business Practices

Support Employee Development

101

GRI

Advance Product Quality and Safety

67 Invest in Our Communities

104

SASB

Engage a Sustainable and Responsible

105

TCFD

Supply Chain

109

Independent Assurance

110

Disclosures and Safe Harbor

Hologic 2024 Sustainability Report

About Hologic

Hologic helps women around the world live healthier lives. We develop life-changing medical technologies that deliver exceptional results essential to effectively detect, diagnose and treat health conditions that affect women globally.

Leadership Message

2024 Highlights

Business Overview

Sustainability Strategy and Governance

Hologic 2024 Sustainability Report

Hologic

Access

Environment

People

Integrity

Appendix

Leadership Message

For nearly four decades, Hologic has championed greater health and well-being for all women - no matter where they live, how much money they make or what their education is - because we believe that women are the cornerstones of society and improving women's health has a powerful ripple effect on families and communities. We firmly believe that our success as a company is fundamentally tied to our ability and commitment to help millions of women worldwide live healthier lives. Because of this belief, we focus on developing industry-leading innovative technologies that enable early detection, diagnosis and treatment of life-changing health conditions that affect women. This is our reason for being.

Our purpose is to enable healthier lives everywhere, every day. Our passion is to champion women's health globally. Our promise

is to deliver The Science of Sure®, a commitment to provide healthcare professionals - and thus patients - with clinically differentiated, high-quality products.

For us, sustainability means delivering strong financial results and creating long-term value for our stakeholders so we can further advance women's health.

Expanded Sustainability Priorities

While we have long integrated sustainability into our strategies and business priorities, this year we have boosted our efforts to create greater impact.

We have expanded our sustainability ambitions and evolved our approach on key environmental, social and governance priorities to better reflect our commitments to a more sustainable and equitable future.

As a science-based company, and with The Science of Sure® as our promise, we have aligned our environmental targets to the

Science Based Targets initiative (SBTi), developed Net Zero emission ambitions by 2050 and submitted our intent for verification.

We maintained a gender zero net pay gap and became a signatory to the United Nations (U.N.) Women Empowerment Principles.

An Enhanced Way of Reporting

Our reporting is now organized into the following focus areas representing the most important topics: advancing women's access and equity in healthcare, protecting the environment, supporting our people and communities, as well as operating with integrity.

This year, we celebrate a decade of growth. During the course of fiscal 2024, each of our divisions grew revenue in the mid-single digits and our core business is now 30% larger compared to 2019. Our innovation engine launched the first and only FDA-cleared digital cytology system - the Genius™ Digital Diagnostics System for cervical cancer screening. In December 2024, we unveiled our next generation Envision™ mammography platform. The Envision platform improves upon our already industry-leading image quality, scan times, workflow and overall patient experience. We also expanded our portfolio through the acquisitions of Endomagnetics® and Gynesonics®. We reached new milestones with more than 210 million COVID assays shipped globally since the pandemic started and more than 193 million lives impacted by Hologic products in FY 2024.

We continue to partner with Gallup® to collect data and insights pertaining to the state of women's health through the Hologic Global Women's Health Index. At Hologic, we are committed to using this data to raise awareness of women's health disparities, advance the standard of care, improve patients' lives and influence change that will drive global policy change.

Additionally, the partnership between Hologic and the Women's Tennis Association® continues to heighten awareness of the importance of

women's health globally, emphasizing the critical importance of early detection and treatment.

I invite you to read more about these and many more highlights in this sustainability report which demonstrates our purpose, passion and promise in action.

Thank you to our employees, customers and partners for championing women's health. We will continue our efforts to deliver the highest standard of care and stand steadfast by our lifelong commitment to providing every woman access to the best products as we help build a more sustainable and equitable future.

Stephen P. MacMillan

Chairman, President and Chief Executive Officer

Stephen P. MacMillan, Chairman, President and CEO

Annual celebration at NASDAQ opening bell to commemorate October as Breast Cancer Awareness Month

Hologic 2024 Sustainability Report

Hologic

Access

Environment

People

Integrity

Appendix

A Year in Review

Fiscal

2024

Business

FDA clearance for Genius™

Digital Diagnostics System for cytology (cervical cancer screening).1

Launched Genius A™ 2.0 technology for breast cancer detection.2

Acquired Endomagnetics and Gynesonics.

3,300+ Panther® molecular diagnostic systems installed worldwide.

Access

146,000 participants and

142 countries and territories represented in fourth year of

Hologic Global Health Index.

Joined United Nation

Women Empowerment Principles as signatory.

Sustainability

10% emission reduction.5

20% water intensity reduction.

65% global landfill diversion.

Completed Scope

3 assessment.

Committed to SBTi and established net zero ambition for 2050.

People

Zero gender net pay gap.6

42% women in global workforce.

98% employees

feel our mission makes their job important.

~$1.8M donated

community grants.

Governance

99.8% of our employees completed Code of Conduct training.

12 sites with

ISO 13485 Certifications.

50% gender diversity on Board of Directors.

90% independent Directors on Board.

Recognition 2024

• Barron's - The 100 Most Sustainable U.S. Companies.

• Great Place To Work - GPTW certification (U.S., Australia and New Zealand).

• Newsweek - America's Most Responsible Companies.

• Eras - Best Employers Eastern Region (U.K.; gold accreditation).

• IMV ServiceTrak - Customer awards in mammography:

• NorthFace - Scoreboard Service Award.

• Forbes - America's Best Midsize Employers.

best service, best customer satisfaction and best system performance.

• Top Workplaces: The Boston Globe - Top Places to Work in Massachusetts.

• Fortune - Best Workplaces in Health Care.

• IMV ServiceTrak - Customer awards in molecular diagnostics:

• Top Workplaces: The News Journal - Top Places to Work in Delaware.

• Fortune - Best Workplaces for Parents.

best customer service and best system performance.

• Top Workplaces: The San Diego Union-Tribune - Best Large Companies.

• Gallup - Exceptional Workplace Award.

• Newsweek - America's Greenest Companies.

• The Wall Street Journal's Top 250: Drucker - Institute's Best-Managed Companies.

Hologic 2024 Sustainability Report

Hologic

Access

Environment

People

Integrity

Appendix

Business Overview

Business Divisions

Diagnostic Solutions (DX)

Surgical Solutions

Breast & Skeletal Health Solutions (BSHS)

Revenue Profile

By Division

By Type

By Geography

16%

19%

25%

Surgical

Service

Intl.

Solutions

19%

Capital

40%

44%

Breast &

62%

75%

Skeletal

Diagnostics

Health Solutions

Solutions

Consumables

U.S.

A Decade of Growth

$6,000

46.5%

$5,632

-12.3%

$5,000

$4,863

-16.3%

-0.2%

$4,000

12.1%

$2,160

5.7%

$1,431

$4,030

4.3%

$3,776

8.3%

$248

$79

5.4%

$3,367

9.9%

$3,218

$3,000

0.4%

$3,059

$929

$2,000

$1,000

$2,511

$2,705

$2,833

$2,851

$2,879

$3,052

$2,782

$3,473

$3,433

$3,782

$3,952

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

Base Business ex. COVID Assays

COVID Assays

Medical Aesthetics

Growth Since 2014

+4.8%

Total Hologic CAGR

+6.4%

Global DX CAGR

+4.5%

Global BSHS CAGR

+7.6%

Global Surgical CAGR

At a Glance

Founded in 1985

Chairman, President & CEO

Stephen P. MacMillan

Fiscal 2024 Revenue

$4.03 billion

NASDAQ Stock Exchange

HOLX

Global Headquarters

Marlborough, MA, USA

Employees

~7,000 worldwide

Patents

4,500+

Estimated Number

of Lives Impacted

>193M in 2024

Global Reach

Locations in 36+ countries and a market presence in more than 100 countries

Note: Growth rates in constant currency, which reflect the revenue results for the applicable period as if the foreign exchange rates were the same as those in the prior year period. Total revenue as reported, except 2014 which excludes $20.1 million one-time revenue impact from amending Roka license. Global Diagnostics CAGR excludes Roka royalty payment of $20.1 million in 2014 and revenue from the divested Blood Screening business of $223.3M in 2014 and $30.3M in 2024. Global Breast & Skeletal Health Solutions CAGR excludes revenue from the divested SSI business of $2.6M in 2024. Base Business revenue decline in 2022 driven by lower capital sales in our Breast & Skeletal Health Solutions business as a result of semiconductor supply chain shortages.

Hologic 2024 Sustainability Report

Sustainability Strategy and Governance

Sustainability Governance

Sustainability is important to how we do business, and we have created a governance structure that facilitates accountability, transparency and continuous improvement.

The Board of Directors governs the oversight of our key sustainability issues across the environmental, social and governance themes.

The Nominating and Corporate Governance Committee (Nom & Gov)

of our Board oversees all of our governance processes, including Hologic's reporting, and efforts related to sustainability.

The ESG & Sustainability Executive Steering Committee is composed of functions relevant to the ESG & Sustainability strategy or whose work is informed by ESG & Sustainability. They provide guidance to the organization on strategy to help up move forward in the most impactful way. The Steering Committee also provides input to the Board in its oversight of the company's sustainability program.

Learn more: Governance Documents

Hologic

Access

Environment

People

Integrity

Appendix

Hologic Board of Directors

Nominating and Corporate Governance Committee

ESG & Sustainability Executive Steering Committee

ESG & Sustainability Functional Group

Hologic 2024 Sustainability Report

SUSTAINABILITY STRATEGY AND GOVERNANCE, CONTINUED

Hologic

Access

Environment

People

Integrity

Appendix

Embedding Sustainability into Our Business and Culture

At Hologic, women's health is more than a business, it is our purpose.

For us, sustainability means delivering strong financial results and creating long-term value for our stakeholders so we can further advance women's health.

Our Purpose

To enable healthier lives everywhere, every day.

Our Passion

To champion women's health globally.

Our Promise

To deliver the Science of Sure®, a commitment to provide healthcare professionals with clinically differentiated, high-quality products.

Our Values

Honesty, integrity, trust, respect, responsibility, citizenship.

Our Sustainability Focus

Advancing Women's Health Access & Equity, Protecting the Environment, Supporting our People & Communities, Operating with Integrity.

Learn more: Sustainability Policy

Advancing

Women's

Health Access

and Equity

Protecting the

Environment

Supporting

our People and

Communities

Operating

with Integrity

Hologic's Virtuous Circle

We are a company that does well by doing good. Hologic's Virtuous Circle represents our corporate objectives and illustrates how delivering better patient outcomes with industry-leading technology generates sustainable business growth while driving benefits for all our stakeholders.

As a science-based company, Hologic has a long-standing approach to operate responsibly and sustainably with unwavering dedication to product quality, clinical differentiation, customer relationships, remarkable talent, engagement, community investment and environmental stewardship.

Our commitments extend beyond our products. We are a catalyst for positive change in the world and as change makers, we are driven to be a force for good.

We are steadfast on our course to improve women's health. With sustainability embedded in our business, we are putting our corporate objectives and our purpose in action. We will continue our efforts to advance the highest standard of science - and work toward providing every woman access to the science we develop as we build a more sustainable and equitable future.

Hologic 2024 Sustainability Report

Hologic

Access

Environment

People

Integrity

Appendix

SUSTAINABILITY STRATEGY AND GOVERNANCE, CONTINUED

Stakeholder Engagement

Customers

Employees

Investors

Patients

Suppliers

Healthcare

Distributors

Regulatory

Industry

The Local

Organizations

Agencies &

Leaders

Communities

Governments

Where We

Operate

Stakeholder Groups

Reporting Frameworks and Benchmark Standards

U.N. Sustainable Development Goals

We routinely engage with each of our stakeholder groups to gather insights. We believe in open and transparent communication as we seek to improve and evolve our sustainability programming.

Our reporting efforts align with the leading frameworks and external benchmarking tools.

As a purpose-driven company, our Sustainability Strategy focuses on delivering positive stakeholder impact and long-term shareholder value. We align our priorities and targets to support the 17 United Nations (U.N.) Sustainable Development Goals (U.N. SDGs) and have identified nine that Hologic can most uniquely affect.

Hologic 2024 Sustainability Report

SUSTAINABILITY STRATEGY AND GOVERNANCE, CONTINUED

Materiality*

Hologic's strategic areas of focus were identified through the process of a sustainability materiality assessment in 2020 and 2023. In 2024, we conducted a desktop refresh to confirm and update the most important topics deemed relevant for Hologic's sustainability strategy based on previously reported themes. We used a combination

of internal and external research to develop a list of initial topics deemed potentially relevant to our evolving sustainability strategy. Following the desktop assessment, informal interviews were conducted with internal and external stakeholders to validate and prioritize topics. Based on the insights gained, we synthesized the updated list of topics and used that information to organize our reporting around the priority focus areas of Access, Environment, People & Communities and Integrity.

We are prioritizing action on the most important environmental, social, and governance (ESG) issues, supported by robust governance, transparency and accountability.

Our materiality assessments guide the sustainability strategy by understanding which issues matter most to our business, our stakeholders, and our impact on society.

In this report, we use the terms "material" and "materiality" to refer to the topics and areas where we believe there can be meaningful Hologic environmental, social and governance impact. The use of such terms shall not be deemed to constitute an admission as to the materiality of any information in this report to Hologic or its stakeholders for purposes of applicable securities laws or any other laws of the United States or other jurisdictions, nor are we using them as they are used in the context of financial statements and financial reporting.

Hologic

Access

Environment

People

Integrity

Appendix

Hologic Sustainability

Environment (E)

Social (S)

Governance (G)

Priority Focus Area

Advancing Women's

Access and Equity

Innovation*

Health Access and Equity

to Healthcare*

Market Presence

Affordability

Protecting the

Climate Action*

Environment

Sustainable Facilities*

Sustainable Supply Chain*

Sustainable Product*

Waste Minimization

Water Conservation

Supporting our People

Talent Attraction, Development,

and Communities

Engagement and Retention*

Workforce Health and Safety

Diversity and Inclusion

Labor Practices

Operating with Integrity

Product Quality and Safety*

Responsible Supply Chain*

Business Ethics and Compliance*

Artificial Intelligence (AI)*

Corporate Governance

Public Policy and Advocacy

Sustainable Economic Growth

Bold * represent the most important issues

Disclaimer

Hologic Inc. published this content on April 21, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 21, 2025 at 23:09 UTC.